We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.7B
1-Year Est. Return 173.77%
This Fund
S&P 500
This Quarter Est. Return
+12.12%
1 Year Est. Return
+173.77%
3 Year Est. Return
+266.65%
5 Year Est. Return
+530.55%
10 Year Est. Return
+2,805.24%
AUM
$2.65B
AUM Growth
+$1.2B
Cap. Flow
+$649M
Cap. Flow %
24.46%
Top 10 Hldgs %
70.55%
Holding
84
New
9
Increased
8
Reduced
22
Closed
13

Top Buys

Rank Stock Value
1
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$1.13B
2
ABUS icon
Arbutus Biopharma
ABUS
+$62.6M
3
CTRA
Coterra Energy
CTRA
+$20.6M
4
AMBA icon
Ambarella
AMBA
+$17.3M
5
PYPL icon
PayPal
PYPL
+$13.2M

Top Sells

Rank Stock Value
1
QIHU
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
+$53.7M
2
Z icon
Zillow
Z
+$24.1M
3
ZG icon
Zillow
ZG
+$22M
4
GS icon
Goldman Sachs
GS
+$16M
5
CYTR
CytRx Corp
CYTR
+$12.1M

Sector Composition

Rank Sector Weight
1 Healthcare 50.73%
2 Miscellaneous 33.77%
3 Financials 3.83%
4 Technology 3.47%
5 Communication Services 2.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIOX
1
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$1.05B 39.58%
+9,375,000
New +$1.13B
XBI icon
2
PUT
State Street SPDR S&P Biotech ETF
XBI
$11.4B
$317M 11.95%
4,781,800
+526,800
+12% +$32.6M
GS icon
3
Goldman Sachs
GS
$301B
$69M 2.6%
427,558
-98,280
-19% -$16M
ABUS icon
4
Arbutus Biopharma
ABUS
$1.03B
$55.1M 2.08%
+16,013,540
New +$62.6M
MMYT icon
5
MakeMyTrip
MMYT
$5.04B
$39.6M 1.49%
1,794,024
-240,000
-12% -$4.56M
INTC icon
6
Intel
INTC
$555B
$35.1M 1.32%
930,004
– –
SRPT icon
7
Sarepta Therapeutics
SRPT
$2.21B
$30.5M 1.15%
496,434
+85,357
+21% +$2.58M
IBB icon
8
iShares Biotechnology ETF
IBB
$10.5B
$27.1M 1.02%
281,190
+100,698
+56% +$9.58M
NRE
9
DELISTED
NorthStar Realty Europe Corp.
NRE
$25.3M 0.96%
2,314,090
-54,516
-2% -$535K
NYT icon
10
New York Times
NYT
$10.9B
$23.3M 0.88%
1,949,409
-378,487
-16% -$4.8M
AGEN
11
Agenus
AGEN
$341M
$23.1M 0.87%
163,993
-23,437
-13% -$2.69M
XLRN
12
DELISTED
Acceleron Pharma
XLRN
$23M 0.87%
636,764
-65,646
-9% -$2.17M
CTRA
13
DELISTED
Coterra Energy
CTRA
$21.3M 0.8%
+824,742
New +$20.6M
EQC
14
DELISTED
Equity Commonwealth
EQC
$20.6M 0.77%
680,000
-120,000
-15% -$3.62M
AMBA icon
15
Ambarella
AMBA
$2.83B
$20.3M 0.77%
+275,877
New +$17.3M
KANG
16
DELISTED
iKang Healthcare Group, Inc.
KANG
$20.2M 0.76%
1,118,340
+226,170
+25% +$4.16M
ARWR icon
17
Arrowhead Research
ARWR
$12.1B
$18.8M 0.71%
2,556,256
+508,474
+25% +$3.3M
ATEX icon
18
Anterix
ATEX
$1.67B
$18.5M 0.7%
902,599
– –
NAT icon
19
PUT
Nordic American Tanker
NAT
$1.52B
$17.8M 0.67%
1,771,560
-55,440
-3% -$644K
THC icon
20
Tenet Healthcare
THC
$21B
$15.3M 0.58%
676,765
-117,692
-15% -$3.06M
ICPT
21
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$15.1M 0.57%
91,881
+18,638
+25% +$2.94M
MRVL icon
22
Marvell Technology
MRVL
$203B
$15.1M 0.57%
1,139,262
-271,900
-19% -$3.19M
IOVA icon
23
Iovance Biotherapeutics
IOVA
$3.95B
$14.3M 0.54%
1,751,509
+153,200
+10% +$1.3M
PYPL icon
24
PayPal
PYPL
$45.6B
$14.1M 0.53%
+344,190
New +$13.2M
XLNX
25
DELISTED
Xilinx Inc
XLNX
$12.9M 0.49%
236,855
– –
1
2 3

Similar funds

AHT
Amanah Holdings Trust London $1.7B AUM 612.53% 1-Year Est. Return
ARAM
Ardmore Road Asset Management New York $1.7B AUM 50.85% 1-Year Est. Return
GC
Gillson Capital Chicago, Illinois $1.7B AUM 16.09% 1-Year Est. Return
TWP
Triad Wealth Partners Lawrence, Kansas $1.7B AUM 21.07% 1-Year Est. Return
FBB
Fulton Breakefield Broenniman Bethesda, Maryland $1.7B AUM 23.97% 1-Year Est. Return
GD
Galaxy Digital New York $1.7B AUM
SG
Sienna Gestion Paris, France $1.71B AUM 43.66% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.71B AUM 0.89% 1-Year Est. Return

QVT Financial's Q3 2016 Portfolio in Review

As of Q3 2016, QVT Financial held 84 positions worth $2.65B, up 83% from $1.45B the previous quarter. Its ten largest holdings account for 71% of the portfolio.

QVT Financial deployed $649M of net new capital in Q3 2016, opening 9 new positions and adding to 8 existing holdings. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 9,375,000 shares worth $1.05B.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, up from 15% a quarter earlier, followed by Miscellaneous and Financials.

On the sell side, the largest reduction was Goldman Sachs, an estimated $16M trimmed.

  • QVT Financial's largest Q3 2016 buy was Sio Gene Therapies Inc. Common Stock: 9,375,000 shares worth $1.05B.
  • QVT Financial added most to iShares Biotechnology ETF in Q3 2016, an estimated $9.58M increase.
  • QVT Financial's biggest Q3 2016 reduction was Goldman Sachs, cutting an estimated $16M.
  • QVT Financial fully exited QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS in Q3 2016, selling an estimated $53.7M.
  • QVT Financial's ten largest holdings make up 71% of its $2.65B portfolio in Q3 2016.
  • QVT Financial opened 9 new positions and closed 13 in Q3 2016.
  • QVT Financial's portfolio value rose 83% quarter-over-quarter to $2.65B.

Based on QVT Financial's 13F filing for Q3 2016, filed 14 Nov 2016.